Targeting the OB-Folds of Replication Protein A with Small Molecules

Replication protein A (RPA) is the main eukaryotic single-strand (ss) DNA-binding protein involved in DNA replication and repair. We have identified and developed two classes of small molecule inhibitors (SMIs) that show in vitro inhibition of the RPA-DNA interaction. We present further characteriza...

Full description

Saved in:
Bibliographic Details
Main Authors: Victor J. Anciano Granadillo, Jennifer N. Earley, Sarah C. Shuck, Millie M. Georgiadis, Richard W. Fitch, John J. Turchi
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Journal of Nucleic Acids
Online Access:http://dx.doi.org/10.4061/2010/304035
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850235309339443200
author Victor J. Anciano Granadillo
Jennifer N. Earley
Sarah C. Shuck
Millie M. Georgiadis
Richard W. Fitch
John J. Turchi
author_facet Victor J. Anciano Granadillo
Jennifer N. Earley
Sarah C. Shuck
Millie M. Georgiadis
Richard W. Fitch
John J. Turchi
author_sort Victor J. Anciano Granadillo
collection DOAJ
description Replication protein A (RPA) is the main eukaryotic single-strand (ss) DNA-binding protein involved in DNA replication and repair. We have identified and developed two classes of small molecule inhibitors (SMIs) that show in vitro inhibition of the RPA-DNA interaction. We present further characterization of these SMIs with respect to their target binding, mechanism of action, and specificity. Both reversible and irreversible modes of inhibition are observed for the different classes of SMIs with one class found to specifically interact with DNA-binding domains A and B (DBD-A/B) of RPA. In comparison with other oligonucleotide/oligosaccharide binding-fold (OB-fold) containing ssDNA-binding proteins, one class of SMIs displayed specificity for the RPA protein. Together these data demonstrate that the specific targeting of a protein-DNA interaction can be exploited towards interrogating the cellular activity of RPA as well as increasing the efficacy of DNA-damaging chemotherapeutics used in cancer treatment.
format Article
id doaj-art-105fba2e831342b5a65de6130732dac8
institution OA Journals
issn 2090-021X
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Journal of Nucleic Acids
spelling doaj-art-105fba2e831342b5a65de6130732dac82025-08-20T02:02:19ZengWileyJournal of Nucleic Acids2090-021X2010-01-01201010.4061/2010/304035304035Targeting the OB-Folds of Replication Protein A with Small MoleculesVictor J. Anciano Granadillo0Jennifer N. Earley1Sarah C. Shuck2Millie M. Georgiadis3Richard W. Fitch4John J. Turchi5Department of Medicine/Hematology and Oncology, Indiana University School of Medicine, Joseph E. Walther Hall, R3-C562, 980 W. Walnut Street, Indianapolis, IN 46202, USADepartment of Medicine/Hematology and Oncology, Indiana University School of Medicine, Joseph E. Walther Hall, R3-C562, 980 W. Walnut Street, Indianapolis, IN 46202, USADepartment of Medicine/Hematology and Oncology, Indiana University School of Medicine, Joseph E. Walther Hall, R3-C562, 980 W. Walnut Street, Indianapolis, IN 46202, USADepartment of Biochemistry and Molecular Biology, Indiana University School of Medicine, Joseph E. Walther Hall, R3-C562, 980 W. Walnut Street, Indianapolis, IN 46202, USADepartment of Chemistry and Physics, Indiana State University, Terre Haute, IN 47809, USADepartment of Medicine/Hematology and Oncology, Indiana University School of Medicine, Joseph E. Walther Hall, R3-C562, 980 W. Walnut Street, Indianapolis, IN 46202, USAReplication protein A (RPA) is the main eukaryotic single-strand (ss) DNA-binding protein involved in DNA replication and repair. We have identified and developed two classes of small molecule inhibitors (SMIs) that show in vitro inhibition of the RPA-DNA interaction. We present further characterization of these SMIs with respect to their target binding, mechanism of action, and specificity. Both reversible and irreversible modes of inhibition are observed for the different classes of SMIs with one class found to specifically interact with DNA-binding domains A and B (DBD-A/B) of RPA. In comparison with other oligonucleotide/oligosaccharide binding-fold (OB-fold) containing ssDNA-binding proteins, one class of SMIs displayed specificity for the RPA protein. Together these data demonstrate that the specific targeting of a protein-DNA interaction can be exploited towards interrogating the cellular activity of RPA as well as increasing the efficacy of DNA-damaging chemotherapeutics used in cancer treatment.http://dx.doi.org/10.4061/2010/304035
spellingShingle Victor J. Anciano Granadillo
Jennifer N. Earley
Sarah C. Shuck
Millie M. Georgiadis
Richard W. Fitch
John J. Turchi
Targeting the OB-Folds of Replication Protein A with Small Molecules
Journal of Nucleic Acids
title Targeting the OB-Folds of Replication Protein A with Small Molecules
title_full Targeting the OB-Folds of Replication Protein A with Small Molecules
title_fullStr Targeting the OB-Folds of Replication Protein A with Small Molecules
title_full_unstemmed Targeting the OB-Folds of Replication Protein A with Small Molecules
title_short Targeting the OB-Folds of Replication Protein A with Small Molecules
title_sort targeting the ob folds of replication protein a with small molecules
url http://dx.doi.org/10.4061/2010/304035
work_keys_str_mv AT victorjancianogranadillo targetingtheobfoldsofreplicationproteinawithsmallmolecules
AT jennifernearley targetingtheobfoldsofreplicationproteinawithsmallmolecules
AT sarahcshuck targetingtheobfoldsofreplicationproteinawithsmallmolecules
AT milliemgeorgiadis targetingtheobfoldsofreplicationproteinawithsmallmolecules
AT richardwfitch targetingtheobfoldsofreplicationproteinawithsmallmolecules
AT johnjturchi targetingtheobfoldsofreplicationproteinawithsmallmolecules